Global and Region Gefitinib Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Gefitinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gefitinibmarket, defines the market attractiveness level of Gefitinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gefitinib industry, describes the types of Gefitinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gefitinib market and the development prospects and opportunities of Gefitinib industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gefitinib market in Chapter 13.

    By Player:

    • Accure Labs

    • Cadila Pharmaceuticals

    • Globela Pharma

    • United Biotech

    • Ethypharm

    • Cipla

    • Celon Laboratories

    • Flagship Biotech International

    • Panacea Biotec

    • Natco Pharma

    • Glenmark Pharmaceuticals

    • Qilu Pharmaceutical

    • Nobel Ilac Sanayii Ve Ticaret

    • Sichuan Xieli Pharmaceutical

    • Nishchay Pharmaceuticals

    • Zuventus Healthcare

    • Jodas Expoim

    • AstraZeneca

    • Dr Reddy's Laboratories

    • Hetero Drugs

    By Type:

    • 10 Tables/Box

    • 30 Tables/Box

    • 90 Tables/Box

    By End-User:

    • Hospital

    • Clinic

    • Drug Center

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gefitinib Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gefitinib Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gefitinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gefitinib Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gefitinib Market Analysis and Outlook to 2022

    • 7.1 Global Gefitinib Consumption (2017-2022)

    • 7.2 United States Gefitinib Consumption (2017-2022)

    • 7.3 Europe Gefitinib Consumption (2017-2022)

    • 7.4 China Gefitinib Consumption (2017-2022)

    • 7.5 Japan Gefitinib Consumption (2017-2022)

    • 7.6 India Gefitinib Consumption (2017-2022)

    • 7.7 South Korea Gefitinib Consumption (2017-2022)

    8 Region and Country-wise Gefitinib Market Analysis and Outlook to 2028

    • 8.1 Global Gefitinib Consumption Forecast (2022-2028)

    • 8.2 United States Gefitinib Consumption Forecast (2022-2028)

    • 8.3 Europe Gefitinib Consumption Forecast (2022-2028)

    • 8.4 China Gefitinib Consumption Forecast (2022-2028)

    • 8.5 Japan Gefitinib Consumption Forecast (2022-2028)

    • 8.6 India Gefitinib Consumption Forecast (2022-2028)

    • 8.7 South Korea Gefitinib Consumption Forecast (2022-2028)

    9 Global Gefitinib Market Outlook by Types and Applications to 2022

    • 9.1 Global Gefitinib Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 10 Tables/Box Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 30 Tables/Box Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global 90 Tables/Box Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gefitinib Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Drug Center Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Gefitinib Market Outlook by Types and Applications to 2028

    • 10.1 Global Gefitinib Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global 10 Tables/Box Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global 30 Tables/Box Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global 90 Tables/Box Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gefitinib Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gefitinib Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gefitinib Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gefitinib Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gefitinib Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gefitinib Market Competitive Analysis

    • 14.1 Accure Labs

      • 14.1.1 Accure Labs Company Details

      • 14.1.2 Accure Labs Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Accure Labs Gefitinib Product and Service

    • 14.2 Cadila Pharmaceuticals

      • 14.2.1 Cadila Pharmaceuticals Company Details

      • 14.2.2 Cadila Pharmaceuticals Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Cadila Pharmaceuticals Gefitinib Product and Service

    • 14.3 Globela Pharma

      • 14.3.1 Globela Pharma Company Details

      • 14.3.2 Globela Pharma Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Globela Pharma Gefitinib Product and Service

    • 14.4 United Biotech

      • 14.4.1 United Biotech Company Details

      • 14.4.2 United Biotech Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 United Biotech Gefitinib Product and Service

    • 14.5 Ethypharm

      • 14.5.1 Ethypharm Company Details

      • 14.5.2 Ethypharm Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ethypharm Gefitinib Product and Service

    • 14.6 Cipla

      • 14.6.1 Cipla Company Details

      • 14.6.2 Cipla Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Cipla Gefitinib Product and Service

    • 14.7 Celon Laboratories

      • 14.7.1 Celon Laboratories Company Details

      • 14.7.2 Celon Laboratories Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Celon Laboratories Gefitinib Product and Service

    • 14.8 Flagship Biotech International

      • 14.8.1 Flagship Biotech International Company Details

      • 14.8.2 Flagship Biotech International Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Flagship Biotech International Gefitinib Product and Service

    • 14.9 Panacea Biotec

      • 14.9.1 Panacea Biotec Company Details

      • 14.9.2 Panacea Biotec Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Panacea Biotec Gefitinib Product and Service

    • 14.10 Natco Pharma

      • 14.10.1 Natco Pharma Company Details

      • 14.10.2 Natco Pharma Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Natco Pharma Gefitinib Product and Service

    • 14.11 Glenmark Pharmaceuticals

      • 14.11.1 Glenmark Pharmaceuticals Company Details

      • 14.11.2 Glenmark Pharmaceuticals Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Glenmark Pharmaceuticals Gefitinib Product and Service

    • 14.12 Qilu Pharmaceutical

      • 14.12.1 Qilu Pharmaceutical Company Details

      • 14.12.2 Qilu Pharmaceutical Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Qilu Pharmaceutical Gefitinib Product and Service

    • 14.13 Nobel Ilac Sanayii Ve Ticaret

      • 14.13.1 Nobel Ilac Sanayii Ve Ticaret Company Details

      • 14.13.2 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Product and Service

    • 14.14 Sichuan Xieli Pharmaceutical

      • 14.14.1 Sichuan Xieli Pharmaceutical Company Details

      • 14.14.2 Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Sichuan Xieli Pharmaceutical Gefitinib Product and Service

    • 14.15 Nishchay Pharmaceuticals

      • 14.15.1 Nishchay Pharmaceuticals Company Details

      • 14.15.2 Nishchay Pharmaceuticals Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Nishchay Pharmaceuticals Gefitinib Product and Service

    • 14.16 Zuventus Healthcare

      • 14.16.1 Zuventus Healthcare Company Details

      • 14.16.2 Zuventus Healthcare Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Zuventus Healthcare Gefitinib Product and Service

    • 14.17 Jodas Expoim

      • 14.17.1 Jodas Expoim Company Details

      • 14.17.2 Jodas Expoim Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Jodas Expoim Gefitinib Product and Service

    • 14.18 AstraZeneca

      • 14.18.1 AstraZeneca Company Details

      • 14.18.2 AstraZeneca Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 AstraZeneca Gefitinib Product and Service

    • 14.19 Dr Reddy's Laboratories

      • 14.19.1 Dr Reddy's Laboratories Company Details

      • 14.19.2 Dr Reddy's Laboratories Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Dr Reddy's Laboratories Gefitinib Product and Service

    • 14.20 Hetero Drugs

      • 14.20.1 Hetero Drugs Company Details

      • 14.20.2 Hetero Drugs Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Hetero Drugs Gefitinib Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gefitinib

    • Figure Gefitinib Picture

    • Table Global Gefitinib Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gefitinib Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gefitinib Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gefitinib Consumption by Country (2017-2022)

    • Figure United States Gefitinib Consumption and Growth Rate (2017-2022)

    • Table Europe Gefitinib Consumption and Growth Rate (2017-2022)

    • Figure China Gefitinib Consumption and Growth Rate (2017-2022)

    • Figure Japan Gefitinib Consumption and Growth Rate (2017-2022)

    • Figure India Gefitinib Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gefitinib Consumption and Growth Rate (2017-2022)

    • Figure Global Gefitinib Consumption Forecast by Country (2022-2028)

    • Figure United States Gefitinib Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gefitinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gefitinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gefitinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gefitinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gefitinib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 10 Tables/Box Consumption and Growth Rate (2017-2022)

    • Figure Global 30 Tables/Box Consumption and Growth Rate (2017-2022)

    • Figure Global 90 Tables/Box Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Center Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global 10 Tables/Box Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 30 Tables/Box Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 90 Tables/Box Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gefitinib Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gefitinib Export by Region (Top 5 Countries) (2017-2028)

    • Table Accure Labs (Foundation Year, Company Profile and etc.)

    • Table Accure Labs Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Accure Labs Gefitinib Product and Service

    • Table Cadila Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Cadila Pharmaceuticals Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Pharmaceuticals Gefitinib Product and Service

    • Table Globela Pharma (Foundation Year, Company Profile and etc.)

    • Table Globela Pharma Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Globela Pharma Gefitinib Product and Service

    • Table United Biotech (Foundation Year, Company Profile and etc.)

    • Table United Biotech Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table United Biotech Gefitinib Product and Service

    • Table Ethypharm (Foundation Year, Company Profile and etc.)

    • Table Ethypharm Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ethypharm Gefitinib Product and Service

    • Table Cipla (Foundation Year, Company Profile and etc.)

    • Table Cipla Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipla Gefitinib Product and Service

    • Table Celon Laboratories (Foundation Year, Company Profile and etc.)

    • Table Celon Laboratories Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celon Laboratories Gefitinib Product and Service

    • Table Flagship Biotech International (Foundation Year, Company Profile and etc.)

    • Table Flagship Biotech International Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Flagship Biotech International Gefitinib Product and Service

    • Table Panacea Biotec (Foundation Year, Company Profile and etc.)

    • Table Panacea Biotec Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Panacea Biotec Gefitinib Product and Service

    • Table Natco Pharma (Foundation Year, Company Profile and etc.)

    • Table Natco Pharma Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natco Pharma Gefitinib Product and Service

    • Table Glenmark Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Glenmark Pharmaceuticals Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glenmark Pharmaceuticals Gefitinib Product and Service

    • Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Qilu Pharmaceutical Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharmaceutical Gefitinib Product and Service

    • Table Nobel Ilac Sanayii Ve Ticaret (Foundation Year, Company Profile and etc.)

    • Table Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nobel Ilac Sanayii Ve Ticaret Gefitinib Product and Service

    • Table Sichuan Xieli Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sichuan Xieli Pharmaceutical Gefitinib Product and Service

    • Table Nishchay Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Nishchay Pharmaceuticals Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nishchay Pharmaceuticals Gefitinib Product and Service

    • Table Zuventus Healthcare (Foundation Year, Company Profile and etc.)

    • Table Zuventus Healthcare Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zuventus Healthcare Gefitinib Product and Service

    • Table Jodas Expoim (Foundation Year, Company Profile and etc.)

    • Table Jodas Expoim Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jodas Expoim Gefitinib Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Gefitinib Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Gefitinib Product and Service

    • Table Hetero Drugs (Foundation Year, Company Profile and etc.)

    • Table Hetero Drugs Gefitinib Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hetero Drugs Gefitinib Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.